Our previous studies have shown that CD147 participates in reprogramming of glucose metabolism (Huang et al., 2014) as well as in lipid metabolism (Li J. et al., 2015) in hepatocellular carcinoma, including de novo lipogenesis and fatty acid-oxidation. The gene discussed is BSG; the disease is hepatocellular carcinoma.